51
Participants
Start Date
October 31, 2004
Primary Completion Date
August 31, 2006
Study Completion Date
August 31, 2006
NicVAX
100 μg, Formulation A, on Days 0, 21, 42, 91 \& 182
NicVAX
200 μg, Formulation A, on Days 0, 21, 42, 91 \& 182
NicVAX
200 μg, Formulation B, on Days 0, 21, 42m 91 \& 182
NicVAX
300 μg, Formulation B, on Days 0, 21, 42, 91 \& 182
NicVAX
400 μg, Formulation B, on Days 0, 21, 42, 91 \& 182
University of Maastricht, Maastricht
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NIH
Nabi Biopharmaceuticals
INDUSTRY